SREBF1 and neoplasm: SREBP1 also has been shown to regulate fatty acid synthesis in immunosuppressive tumor-associated macrophages (TAMs); SREBP1 was evaluated as a potential novel target to augment the efficacy of immune checkpoint blockades and improve cancer immunotherapy [14].